Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,197
archived clinical trials in
Atrial Fibrillation

Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
1956
mi
from 43215
Laguna Hills, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
1956
mi
from 43215
Laguna Hills, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
2041
mi
from 43215
Sacramento, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
2041
mi
from 43215
Sacramento, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
2039
mi
from 43215
Sacramento, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
2039
mi
from 43215
Sacramento, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
1963
mi
from 43215
Santa Ana, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
1963
mi
from 43215
Santa Ana, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
1958
mi
from 43215
Tustin, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
1958
mi
from 43215
Tustin, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
1943
mi
from 43215
Vista, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
1943
mi
from 43215
Vista, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
1154
mi
from 43215
Aurora, CO
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
1154
mi
from 43215
Aurora, CO
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
522
mi
from 43215
Bridgeport, CT
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
522
mi
from 43215
Bridgeport, CT
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
397
mi
from 43215
Wilmington, DE
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
397
mi
from 43215
Wilmington, DE
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
957
mi
from 43215
Naples, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
957
mi
from 43215
Naples, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
766
mi
from 43215
Crystal River, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
766
mi
from 43215
Crystal River, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
749
mi
from 43215
Daytona Beach, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
749
mi
from 43215
Daytona Beach, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
754
mi
from 43215
Dunnellon, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
754
mi
from 43215
Dunnellon, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
976
mi
from 43215
Hollywood, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
976
mi
from 43215
Hollywood, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
670
mi
from 43215
Jacksonville, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
670
mi
from 43215
Jacksonville, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
673
mi
from 43215
Jacksonville, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
673
mi
from 43215
Jacksonville, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
747
mi
from 43215
Ocala, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
747
mi
from 43215
Ocala, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
832
mi
from 43215
Melbourne, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
832
mi
from 43215
Melbourne, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Maine Research Associates
714
mi
from 43215
Auburn, ME
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Maine Research Associates
714
mi
from 43215
Auburn, ME
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
994
mi
from 43215
Miami, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
994
mi
from 43215
Miami, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
897
mi
from 43215
Port Charlotte, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
897
mi
from 43215
Port Charlotte, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
815
mi
from 43215
Rockledge, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
815
mi
from 43215
Rockledge, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
876
mi
from 43215
Sarasota, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
876
mi
from 43215
Sarasota, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
427
mi
from 43215
Atlanta, GA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
427
mi
from 43215
Atlanta, GA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Rockdale Medical Research Associates
441
mi
from 43215
Conyers, GA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Rockdale Medical Research Associates
441
mi
from 43215
Conyers, GA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Northeast Georgia Heart Center, PC
393
mi
from 43215
Gainesville, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Northeast Georgia Heart Center, PC
393
mi
from 43215
Gainesville, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
316
mi
from 43215
Bloomington, IL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
316
mi
from 43215
Bloomington, IL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
270
mi
from 43215
Chicago, IL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
270
mi
from 43215
Chicago, IL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
408
mi
from 43215
Rock Island, IL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
408
mi
from 43215
Rock Island, IL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
135
mi
from 43215
Ft Wayne, IN
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
135
mi
from 43215
Ft Wayne, IN
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
185
mi
from 43215
Indianapolis, IN
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
185
mi
from 43215
Indianapolis, IN
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
125
mi
from 43215
Muncie, IN
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
125
mi
from 43215
Muncie, IN
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
566
mi
from 43215
Des Moines, IA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
566
mi
from 43215
Des Moines, IA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
109
mi
from 43215
Florence, KY
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
109
mi
from 43215
Florence, KY
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
156
mi
from 43215
Lexington, KY
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
156
mi
from 43215
Lexington, KY
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
VA North Texas Health Care System
914
mi
from 43215
Dallas, TX
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
VA North Texas Health Care System
914
mi
from 43215
Dallas, TX
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
266
mi
from 43215
Owensboro, KY
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
266
mi
from 43215
Owensboro, KY
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
798
mi
from 43215
Alexandria, LA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
798
mi
from 43215
Alexandria, LA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
845
mi
from 43215
Lafayette, LA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
845
mi
from 43215
Lafayette, LA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
788
mi
from 43215
Shreveport, LA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
788
mi
from 43215
Shreveport, LA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
714
mi
from 43215
Auburn, ME
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
714
mi
from 43215
Auburn, ME
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
344
mi
from 43215
Baltimore, MD
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
344
mi
from 43215
Baltimore, MD
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Palmetto Clinical Trial Services
357
mi
from 43215
Greenville, SC
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Palmetto Clinical Trial Services
357
mi
from 43215
Greenville, SC
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
331
mi
from 43215
Columbia, MD
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
331
mi
from 43215
Columbia, MD
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
414
mi
from 43215
Salisbury, MD
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
414
mi
from 43215
Salisbury, MD
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Charles River Medical Associates
627
mi
from 43215
Natick, MA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Charles River Medical Associates
627
mi
from 43215
Natick, MA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
164
mi
from 43215
Detroit, MI
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
164
mi
from 43215
Detroit, MI
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
213
mi
from 43215
Flint, MI
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
213
mi
from 43215
Flint, MI
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
206
mi
from 43215
Kalamazoo, MI
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
206
mi
from 43215
Kalamazoo, MI
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
205
mi
from 43215
Lansing, MI
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
205
mi
from 43215
Lansing, MI